Malignant mixed mullerian tumor secondary to tamoxifen for Ca breast: Shadow of the past!

Autor:	Vinu Choudhary, Surendra Bisu
Rok vydání:	2018
Předmět:	Health (social science) Uterus Medicine (miscellaneous) Case Report Malignant mixed Mullerian tumor lcsh:Geriatrics lcsh:Gynecology and obstetrics Pathogenesis Breast cancer medicine Endometrial Polyp Antioestrogenic effect skin and connective tissue diseases lcsh:RG1-991 tamoxifen business.industry medicine.disease Endometrial hyperplasia lcsh:RC952-954.6 medicine.anatomical_structure Cancer research business malignant mixed mullerian tumor hormones hormone substitutes and hormone antagonists Tamoxifen medicine.drug
Zdroj:	Journal of Mid-Life Health Journal of Mid-Life Health, Vol 9, Iss 4, Pp 210-211 (2018)
ISSN:	0976-7800
DOI:	10.4103/jmh.jmh_79_18
Popis:	Tamoxifen is used in the treatment of hormone-responsive breast cancer because of its antiestrogenic effect. However, it also has an estrogenic effect on the uterus, thereby increasing the risk of endometrial hyperplasia, endometrial polyp, and malignant mixed Mullerian tumor (MMMT). This case describes the pathogenesis and risk of MMMT due to long-term tamoxifen intake in hormone-responsive breast cancer.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf80fa06c33981ab27ab1f93bc53cddf https://doi.org/10.4103/jmh.jmh_79_18 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.